CDK4 and colorectal carcinoma: Therefore, looking for specific inhibitors that regulate CDK4, developing highly selective drugs for CDK4, and preparing reasonable and effective combined strategies for specific patients are of great significance for improving the clinical treatment effect of CRC patients (38).